Thursday, 17 May 2018

Male patients may respond better to cancer immunotherapy treatment

New research from the European Institute of Oncology in Milan, Italy, indicates that men may respond more positively to cancer immunotherapy treatments than females.  According to study author Dr. Fabio Conforti, research on more than 11,000 patients in the study determined that all patients, regardless of gender, "fared better on immunotherapy treatment than they would have on another treatment, or no treatment at all."  However, these findings also indicate that "male cancer patients saw their survival extended by twice as much as female patients."

To read more about this study, click here.

No comments:

Post a Comment